We are live on
!
Find out more
AA
AlphaMark Advisors Portfolio holdings
AUM
$231M
1-Year Est. Return
19.98%
This Fund
S&P 500
This Quarter
Est. Return
+5.09%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$168M
AUM Growth
+$5.28M
(+3.3%)
Cap. Flow
-$1.1M
Cap. Flow
% of AUM
-0.65%
Top 10 Holdings %
Top 10 Hldgs %
28.41%
Holding
314
New
29
Increased
45
Reduced
71
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.64M |
| 2 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$788K |
| 3 |
Universal Electronics
UEIC
|
+$598K |
| 4 |
ASRT
Assertio
ASRT
|
+$584K |
| 5 |
TAL Education Group
TAL
|
+$557K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perrigo
PRGO
|
+$3.81M |
| 2 |
Vaalco Energy
EGY
|
+$945K |
| 3 |
The Ensign Group
ENSG
|
+$787K |
| 4 |
PVH
PVH
|
+$693K |
| 5 |
CYNO
Cynosure, Inc. Class A
CYNO
|
+$674K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.79% |
| 2 | Healthcare | 16.33% |
| 3 | Industrials | 9.84% |
| 4 | Consumer Discretionary | 8.38% |
| 5 | Financials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Delta Air Lines
DAL
$57.5B
| $2.95M | 1.76% |
76,073
-1,333
| -2% | -$50.3K |
|
27
KLA
KLAC
$239B
| $2.91M | 1.73% |
400,560
-2,180
| -0.5% | -$14.5K |
|
28
Waste Management
WM
$90.6B
| $2.85M | 1.7% |
63,803
-505
| -0.8% | -$22K |
|
29
Ross Stores
ROST
$80.5B
| $2.85M | 1.7% |
86,186
+2,062
| +2% | +$70.8K |
|
30
Verizon
VZ
$195B
| $2.81M | 1.68% |
57,471
-42
| -0.1% | -$2.04K |
|
31
Eastman Chemical
EMN
$8B
| $2.56M | 1.52% |
29,271
-498
| -2% | -$43.3K |
|
32
Lumen
LUMN
$6.57B
| $2.55M | 1.52% |
70,390
-538
| -0.8% | -$19.3K |
|
33
Open Text
OTEX
$6.15B
| $2.53M | 1.51% |
105,648
+1,344
| +1% | +$31.9K |
|
|
EMC
34
DELISTED
EMC CORPORATION
EMC
| $2.42M | 1.44% |
92,046
+2,075
| +2% | +$54.8K |
|
35
US Bancorp
USB
$98.2B
| $2.05M | 1.22% |
47,220
| – | – |
|
36
iShares TIPS Bond ETF
TIP
$14.5B
| $1.88M | 1.12% |
16,305
-485
| -3% | -$55.2K |
|
|
MNTA
37
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $1.55M | 0.93% |
128,714
+66,714
| +108% | +$788K |
|
38
abrdn Physical Gold Shares ETF
SGOL
$6.91B
| $800K | 0.48% |
61,350
-1,000
| -2% | -$12.7K |
|
|
HF
39
DELISTED
HFF Inc.
HF
| $758K | 0.45% |
20,371
| – | – |
|
|
HOLI
40
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $735K | 0.44% |
30,000
| – | – |
|
|
WPS
41
DELISTED
iShares International Developed Property ETF
WPS
| $733K | 0.44% |
18,775
-900
| -5% | -$34.3K |
|
42
Welltower
WELL
$169B
| $724K | 0.43% |
11,545
+25
| +0.2% | +$1.57K |
|
|
43
Universal Electronics
UEIC
$57.8M
| $709K | 0.42% |
+14,500
| New | +$598K |
|
|
AIMC
44
DELISTED
Altra Industrial Motion Corp
AIMC
| $706K | 0.42% |
19,400
-2,300
| -11% | -$80.8K |
|
45
Genesco
GCO
$425M
| $705K | 0.42% |
8,581
-1,600
| -16% | -$122K |
|
46
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.3B
| $696K | 0.41% |
14,915
-300
| -2% | -$13.7K |
|
47
Belden
BDC
$4.83B
| $694K | 0.41% |
8,882
-1,000
| -10% | -$73.4K |
|
48
Global Partners
GLP
$1.68B
| $685K | 0.41% |
16,850
-3,600
| -18% | -$145K |
|
49
The Greenbrier Companies
GBX
$1.52B
| $680K | 0.41% |
11,800
-4,200
| -26% | -$219K |
|
|
NTUS
50
DELISTED
Natus Medical Inc
NTUS
| $671K | 0.4% |
26,700
| – | – |
|
Similar funds
AJ
MWS
LHR
HPFG
GWM
KC
SL
CSWM
AlphaMark Advisors's Q2 2014 Portfolio in Review
As of Q2 2014, AlphaMark Advisors held 314 positions worth $168M, up 3.3% from $162M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
AlphaMark Advisors's Q2 2014 filing shows 29 new, 45 increased, 71 reduced and 9 closed positions. Its largest new stake was Gilead Sciences: 46,823 shares worth $3.88M. The largest sale was Perrigo, an estimated $3.81M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.
- AlphaMark Advisors's largest Q2 2014 buy was Gilead Sciences: 46,823 shares worth $3.88M.
- AlphaMark Advisors added most to Momenta Pharmaceuticals, Inc. in Q2 2014, an estimated $788K increase.
- AlphaMark Advisors's biggest Q2 2014 reduction was Perrigo, cutting an estimated $3.81M.
- AlphaMark Advisors fully exited Vaalco Energy in Q2 2014, selling an estimated $945K.
- AlphaMark Advisors's ten largest holdings make up 28% of its $168M portfolio in Q2 2014.
- AlphaMark Advisors opened 29 new positions and closed 9 in Q2 2014.
- AlphaMark Advisors's portfolio value rose 3.3% quarter-over-quarter to $168M.
Based on AlphaMark Advisors's 13F filing for Q2 2014, filed 29 Jul 2014.